TNF and COVID-19: As catecholamines are able to diminish the T-helper cell type 1 cell-mediated cytokine response mediated by, e.g., interleukins (IL) 1, 2, 12 or IFN-γ and tumor necrosis factor alpha (TNF-α), viral replication may be facilitated in patients with COVID-19 [17].